DisclosureWe earn commission on partner links; ranking is set by our published methodology — not advertisers.
Wegovy Pill (oral semaglutide 25mg) costs $149–$299/month (dose-tiered) via NovoCare Pharmacy self-pay, $25/month with insurance + savings card, or up to $1,349.02/month list retail. Updated for 2026.
Same drug, different pricing channels. The spread is often $800-1000/month between cheapest and retail cash.
| Channel | Source | |
|---|---|---|
Cash-pharmacy + savings card Commercially insured with coverage — manufacturer copay card (GoodRx/SingleCare style discount otherwise). | ~$25 with commercial insurance (max savings $100/month)Best value | Manufacturer savings card terms |
With insurance (covered, after PA) Commercial plan that covers the drug after prior authorization — copay depends on your tier. | $25/month – $150/month | Plan formulary copay tiers |
Manufacturer cash — NovoCare Pharmacy self-pay Anyone with a valid prescription who pays cash — no insurance required, valid in all 50 states. | $149–$299/month (dose-tiered)Lowest | NovoCare |
Retail / list (cash, no programs) Walk-in pharmacy price with no insurance, savings card, or manufacturer program. | $1,349.02/month listList price | WAC / pharmacy list, LoseLab pricing desk |
We’ll email you the day it gets cheaper — no spam, unsubscribe anytime.
The Wegovy pill lists at $1,349.02 per package, but NovoCare Pharmacy self-pay is the real cash number and it is dose-tiered: about $149/month on the starter doses (1.5 mg and 4 mg) and about $299/month on the maintenance doses (9 mg and 25 mg). Since standard titration takes most people to a maintenance dose, ~$299/month is the realistic long-run self-pay figure — the $149 applies mainly to your first months.
If your commercial plan covers the Wegovy pill, the Wegovy savings offer brings eligible patients to about $25/month — with an important cap: maximum savings of $100/month, so a high-tier copay can leave you paying more than $25. As a 2026 launch, formulary placement is still rolling out; expect prior authorization and confirm your plan has added the oral form specifically (some plans list the injection but not yet the tablet).
Three levers: (1) the Wegovy savings offer — ~$25/month for eligible commercially insured patients, $100/month maximum savings, enroll via NovoCare; (2) NovoCare Pharmacy self-pay — $149/month starter doses, $299/month maintenance doses, no insurance needed; (3) the announced Medicare pathway — eligible Part D patients expected to pay ~$50/month from July 1, 2026 under the government GLP-1 pricing agreement.
Under the announced government GLP-1 pricing agreement, eligible Medicare Part D patients are expected to access oral Wegovy for about $50/month beginning July 1, 2026. That is a program announcement, not automatic plan coverage — Part D formularies list drug-by-drug, so confirm with your plan before counting on it.
State Medicaid coverage of the oral form is still forming post-launch; states that already cover injectable Wegovy for obesity are the likeliest early adopters, but the tablet needs its own formulary listing. Check your state formulary or our state-by-state Medicaid pages for verified status.
The other 2026 oral GLP-1 — self-pay from ~$149/month, no food/water timing rules (the Wegovy pill is also once daily). Different molecule (non-peptide small molecule); compare on the dose you would maintain.
$499/month flat via NovoCare — same molecule, weekly shot instead of daily tablet, and the form with the STEP-1 ~15% trial record and CV-risk indication.
$349–$499/month via LillyDirect vials — weekly injection with the highest trial efficacy in the class (~21% in SURMOUNT-1).
Real-world Wegovy pill cost in 2026: ~$25/month if commercially insured with coverage (mind the $100/month savings cap), $149/month self-pay while on starter doses, $299/month self-pay at the maintenance doses most people reach, and an expected ~$50/month Medicare pathway from July 2026. Same semaglutide molecule as the injection at the oral 25 mg dose — the pill wins on needle-free convenience and monthly price, while the injection keeps the deepest trial record.
Pricing verified monthly against current manufacturer and pharmacy formularies. Coverage rules vary by plan — verify against your member portal before prescribing.